Clinical Trials for Aclaris Therapeutics

Explore 3 clinical trials worldwide

Showing 1-3 of 3 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Aclaris Therapeutics

Clinical Trials (3)

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

PHASE2Recruiting

96 participants

Started: May 30, 2025 · Completed: Oct 31, 2026

5 conditions1 sponsor24 locations

MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma

PHASE1Recruiting

51 participants

Started: May 15, 2025 · Completed: May 31, 2030

3 conditions3 sponsors1 location

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

PHASE1/PHASE2Recruiting

152 participants

Started: Jan 30, 2025 · Completed: May 31, 2032

1 condition3 sponsors3 locations